The present study examined the effects of antimicrobial agents on a biofilm model of Staphylococcus aureus. A membranous structure (an immature biofilm) was formed on the coverslips of tissue culture dishes by S. aureus cells in plasma after incubation for 24 h. After incubation, the colony counts of S. aureus cells in the immature biofilms in plasma containing levofloxacin with 70% sucrose were about one-tenth of those in plasma containing levofloxacin without sucrose. The colony counts of S. aureus cells in the immature biofilms in plasma containing silver sulphadiazine or silver nitrate (at a silver concentration of 0.302%) were over 3000 times lower than those in control plasma without silver after incubation for 24 h. Plasma coagulation by S. aureus cells was not detected in plasma containing 70% sucrose 48 h after inoculation. The immature biofilms were incubated in plasma with and without 70% sucrose, and the immature biofilms were treated with 10% povidone-iodine for 2 min after incubation for 4 and 16 h. In this experiment, the colony counts of S. aureus cells in the immature biofilms incubated with 70% sucrose were about one-tenth of those in plasma without sucrose after incubation for 24 h. We suggest that levofloxacin or 10% povidoneiodine in combination with 70% sucrose and silver sulphadiazine or silver nitrate (at a silver concentration of 0.302%) are effective in eliminating S. aureus cells in a biofilm.
Introduction
Biofilms are complex associations of microorganisms and glycocalyx attached to a surface. [1] [2] [3] In our previous studies, we observed membranous structures (i.e. biofilms) produced by Staphylococcus aureus cells on silk thread stitches in the skin, 4 in croton-oil-inflamed skin 5 and in cut wounds in mice 6 when the animals were in a neutropenic condition. Staphylococcus aureus cells isolated from impetigo, furuncle and atopic dermatitis lesions produced a biofilm in plasma on plastic tissue culture coverslips after incubation for 72 h at 37°C. 7, 8 The purpose of the present study was to examine the in-vitro antimicrobial effects of levofloxacin, 10% povidone-iodine, 70% sucrose, 1% silver sulphadiazine (containing 0.698% sulphadiazine and 0.302% silver), or other types of silver (at a silver concentration of 0.302%) on a biofilm of S. aureus cells and on the coagulation of plasma by S. aureus cells.
Materials and methods

Bacterial strains
Two strains of S. aureus isolated from staphylococcal impetigo and furuncle lesions were used. The impetigo strain was of coagulase type V (latex agglutination method), and produced exfoliative toxin A (ETA). 9 The furuncle strain was of coagulase type IV. The MICs of oxacillin, levofloxacin, sulphadiazine and silver sulphadiazine for these strains were 0.25, 1, 256 and 64 mg/L, respectively. These strains produced a mature biofilm in plasma on coverslips after 72 h at 37°C. 7 Four other S. aureus strains isolated from impetigo lesions (two of coagulase type I (ETB producers) and two of coagulase type V (ETA producers)) and one S. aureus strain isolated from furuncle lesion (coagulase type IV) were also used to examine plasma coagulation.
MICs of sulphadiazine (Daiichi Pharmaceutical Co., Tokyo, Japan) and silver sulphadiazine (TokyoTanabe Pharmaceutical Co., Tokyo, Japan) were determined against 12 S. aureus strains isolated from impetigo lesions (five of coagulase type I (ETB producers); seven of coagulase type V (ETA producers)) and 12 S. aureus strains isolated from furuncle lesions (coagulase type IV). Of the 24 S. aureus strains, 12 were methicillin-sensitive S. aureus (MSSA) (oxacillin MIC 2 mg/L) and 12 were methicillin-resistant S. aureus (MRSA) (oxacillin MIC 4 mg/L).
Bacterial suspension for inoculation
S. aureus strains were grown in 8 mL of tryptic soy broth (TSB; Nissui Pharmaceutical Co., Tokyo, Japan) at 37°C for 24 h without shaking. Following incubation, the bacterial cells were harvested by centrifugation at 9000g for 10 min at 4°C. The bacterial cells were then resuspended in sterile saline solution and centrifuged as described above. The washed bacteria were resuspended in 1 mL polypropylene microcentrifuge tubes (Iuchi BioSystems, Tokyo, Japan) and tissue culture dishes (35 mm 10 mm; Becton Dickinson Co., Lincoln Park, NJ, USA) (n 4).
In-vitro attachment of S. aureus cells to plastic tissue culture coverslips
We examined the attachment of S. aureus cells to plastic tissue culture coverslips (Sumitomo Bakelite Co., Tokyo, Japan). The coverslips were incubated with S. aureus c e l l s in culture medium for 24 h at 37°C, and then gently washed with sterile saline solution (1 mL) ten times. The coverslips were suspended in 4 mL of sterile saline solution and sonicated (Ultrasonics Inc. Model W-225R) at 60% power for 30 s at 4°C. The organisms stripped from the coverslips were counted as cfu using a ten-fold dilution method.
S. aureus cell count in immature biofilms under various conditions
Cell suspensions of S. aureus strains isolated from an impetigo lesion and a furuncle lesion, containing 1.5 10 9 and 1.8 10 9 cfu respectively, were used to inoculate 2.5 mL of rabbit plasma (Denka Seiken, Tokyo, Japan) on 1.77 cm 2 of coverslips in tissue culture dishes. After incubation for 24 h at 37°C, immature biofilms had formed on the coverslips. The immature biofilms (n 4) were placed in 2.5 mL of rabbit plasma alone, or rabbit plasma with levofloxacin (Daiichi Pharmaceutical Co.) at 2 or 4 MIC with or without 70% sucrose (Kowa Co., Tokyo, Japan). After incubation for 24 h at 37°C, the number of S. aureus cells attached to each coverslip was determined, and observations were made for plasma coagulation. Levofloxacin, which is commonly used in the dermatological field in Japan, was used, because it has good antistaphylococcal activity.
The immature biofilms (n 4) that were produced by the strain isolated from furuncle were incubated in 2.5 mL of rabbit plasma with and without 70% sucrose. After 4 h and 16 h incubations, the immature biofilms were transferred to fresh dishes. The immature biofilms were treated with 2.5 mL of 10% povidone-iodine solution (Meiji Seika Co.) for 2 min, followed by an equal amount of 5% sodium thiosulphate (Wako Pure Chemical Industries, Ltd, Tokyo, Japan). 8 The immature biofilms were returned to the original dishes after treatment with povidoneiodine. After incubation for 24 h at 37°C, the number of S. aureus cells attached to each coverslip was determined and checked for plasma coagulation.
Observation of plasma coagulation under various conditions
Cell suspensions of the seven S. aureus strains containing 4.2 10 7 -1.8 10 8 cfu were used to inoculate 1 mL of rabbit plasma either alone (control), or supplemented with 70%, 50% or 30% sucrose, or with 50% or 30% glucose (Nakarai Chemicals, Ltd, Kyoto, Japan) in microcentrifuge tubes. Plasma coagulation was checked after incubation for 4, 24 or 48 h at 37°C. The osmotic pressure levels of rabbit plasma, measured by Kitasato Biochemical Laboratories (Tokyo, Japan), were as follows: rabbit plasma only, 274 mOsm/kg H 2 O; with 30% sucrose, 1446 mOsm/kg H 2 O; with 50% sucrose and 30% glucose the osmotic pressure was higher than that of rabbit plasma containing 30% sucrose so could not be measured.
Effect of sucrose on the multiplication rate of S. aureus
Cell suspensions of S. aureus strains isolated from an impetigo lesion and a furuncle lesion were used to inoculate 1 mL of TSB alone (control) and TSB with 70% sucrose in microcentrifuge tubes. After incubation for 24 h at 37°C, the organisms were counted as cfu using a ten-fold dilution method (n 4).
Determination of MICs of sulphadiazine and silver sulphadiazine
The MICs of sulphadiazine and silver sulphadiazine against 24 S. aureus strains were determined using a Mueller-Hinton (Difco Laboratories, Detroit, MI, USA) agar plate method (inoculum size: 10 6 cfu/mL).
Effect of sulphadiazine, silver sulphadiazine, and other types of silver on the multiplication rate of S. aureus
Cell suspensions of S. aureus strains isolated from an impetigo lesion and a furuncle lesion were used to inoculate 1 mL of TSB alone (control), TSB with 0.698% sulphadiazine, TSB with 1% silver sulphadiazine, TSB with silver chloride (AgCl) (containing 0.302% silver; Sigma Chemical Co.), and TSB with silver nitrate (AgNO 3 ) (containing 0.302% silver; Nakalai Chemicals, Ltd) in microcentrifuge tubes, and throughly mixed for 1 min using a touch mixer (MT-31: Yamato Co., Tokyo, Japan). After incubation for 24 h at 37°C, the organisms were counted (as cfu) using a ten-fold dilution method (n 4). All silver solutions were protected from light.
Effects of sulphadiazine, silver sulphadiazine and other types of silver on immature biofilms
Cell suspensions of S. aureus strains isolated from an impetigo lesion and a furuncle lesion containing 7.4 10 8 and 6.6 10 8 cfu were used to inoculate 2.5 mL of rabbit plasma on 1.77 cm 2 of coverslips in tissue culture dishes. After incubation for 24 h at 37°C, immature biofilms had formed on the coverslips. All silver solutions were throughly mixed for 1 min using a touch mixer before treatment. The immature biofilms (n 4) were then used to inoculate 2.5 mL of rabbit plasma either alone (control) or supplemented with 0.698% sulphadiazine, 1% silver sulphadiazine, silver chloride (containing 0.302% silver) or silver nitrate (containing 0.302% silver). After incubation for 24 h at 37°C, the number of S. aureus cells attached to each coverslip was determined and checked for plasma coagulation. All silver solutions were protected from light.
Statistical analysis was not performed, as the sample sizes were too small.
Results
The colony counts in immature biofilms incubated in plasma containing levofloxacin at 2 or 4 MIC with 70% sucrose were about one-tenth of those in plasma containing levofloxacin at 2 or 4 MIC without sucrose (Table  Ia) . In the experiment with povidone-iodine (Table Ib) , the colony counts of S. aureus cells in immature biofilms in plasma with 70% sucrose were about one-tenth of those in plasma without sucrose after incubation for 24 h.
The seven S. aureus strains did not cause detectable plasma coagulation in plasma with 70% sucrose or 50% glucose after 4, 24 or 48 h of incubation (Table II) . The final pH levels of rabbit plasma were as follows: rabbit plasma only, pH 6.3; with 70% sucrose, pH 6.8; with 50% glucose, pH 6.2.
The colony counts in TSB with 70% sucrose were not lower than those in TSB alone (control) ( Table III) .
The MIC of sulfadiazine for 24 S. aureus strains showed a peak MIC distribution at 256 mg/L. The MIC of silver sulfadiazine for 24 S. aureus strains showed a peak MIC distribution at 64 mg/L.
The colony counts in TSB with silver sulphadiazine or silver nitrate (at a silver concentration of 0.302%) were about 50 or 100 times lower than those in TSB alone (control) ( Table IVa) . The final pH of the TSB was as follows: TSB only, pH 6.4; with 0.698% sulphadiazine, pH 6.2; with 1% silver sulphadiazine, pH 6.8; with silver chloride, pH 7.0; with silver nitrate, pH 6.2. The colour of the bottoms of microcentrifuge tubes turned dark in the presence of silver compounds after incubation for 24 h. The colony counts in immature biofilms in plasma with silver sulphadiazine or silver nitrate (at a silver concentration of 0.302%) were more than 3000 times lower than those in plasma alone (control) ( Table IVb) . The colour of the bottoms of dishes and immature biofilms turned dark in the presence of silver compounds after incubation for 24 h. 
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Discussion
Sugar paste has long been used in the topical therapy of pressure ulcers. 10 Gordon et al. 11 reported that sugar (sucrose) can be used to deslough infected wounds and to assist the formation of granulation tissue formation, with the occasional promotion of bleeding. Chirife et al. 12 reported that, in the treatment of infected wounds, sugar creates an environment of low water activity which inhibits or stresses bacterial growth. When wounds are filled with sugar, the sugar dissolves in the tissue water and creates an environment of low water activity which inhibits bacterial growth. 13 Staphylococcus aureus is highly resistant to low water activities. 13, 14 Chirife et al. 13 reported that S. aureus grows at a sugar concentration of 183 g of sugar/100 g of water, but is completely inhibited at a concentration of 195 g of sugar/100 g of water. In this report, we also confirmed that plasma coagulation by S. aureus was inhibited in the presence of 70% sucrose.
We have reported that the attachment of S. aureus c e l l s isolated from atopic dermatitis lesions to the coverslips was suppressed in the presence of 10% NaCl or 10% sea salt. 1 5 In addition, we have reported that the attachment of S . a u r e u s cells isolated from atopic dermatitis lesions and impetigo lesions was suppressed in the presence of 5% ZnO and that plasma coagulation by these strains was not detected in plasma with 5% ZnO after incubation for 24 h at 3 7 ° C . 1 6 The colony counts in immature biofilms were lower in plasma with levofloxacin at 4 MIC containing 5% ZnO than in plasma with levofloxacin at 4 MIC alone. 1 6 W e have reported that the attachment of S. aureus cells to coverslips was suppressed in the presence of 5% ZnO and that antistaphylococcal activity of levofloxacin increased in the presence of 5% ZnO. 1 6 The growth rate of S. aureus cells isolated from an impetigo lesion and a furuncle lesion in TSB with 70% sucrose was not inhibited, compared with the growth rate of cells in TSB alone (control) after incubation for 24 h at 37°C (Table III) . In plasma with 50% glucose (Table II) or with 20% NaCl or 40% glycerol (data not shown), there was no detectable plasma coagulation by s e v e n S. aureus strains after incubation for 48 h at 37°C. This may have been a result of the higher osmotic pressure of these media. We suggest that, although S. aureus c a n grow in media of a high osmotic pressure, such as plasma with 70% sucrose, plasma coagulation by S. aureus cells is inhibited by such a high osmotic pressure.
The first step in the establishment of an infection is the attachment of bacteria to tissues. Fibrinogen contributes to the attachment of S. aureus cells to coverslips in plasma. 15 The attachment of S. aureus cells to coverslips, the conversion of fibrinogen to fibrin, and the production of an abundant glycocalyx by S. aureus cells are the minimum requirement for the production of biofilm on coverslips. 7 The S. aureus cells used in this experiment produced a mature biofilm in plasma on coverslips after 72 h at 37°C. The membranous structures formed on coverslips by these strains in rabbit plasma after incubation for 24 h at 37°C may be an immature biofilm. We found that the antistaphylococcal activity of povidoneiodine in immature biofilms was increased on addition of 70% sucrose to plasma (Table Ib) . If plasma coagulation does not occur in the presence of 70% sucrose, the adherence of S. aureus cells will probably be inhibited, leading to the suppression of staphylococcal infections.
Topical use of silver sulfadiazine has been shown to be beneficial in the treatment and prevention of burn infections. 17, 18 Maple et al. 19 reported that silver sulfadiazine (at its MIC 50 of 85 mg/L) was rapidly bactericidal in time-kill experiments on 80 strains of MRSA. Maple et al. 19 also reported that there were no resistant mutants to silver sulphadiazine in an inoculum of 10 9 cfu of MRSA and that silver sulphadiazine could be of use for clearing up staphylococcal carriage. With regard to the mechanism of action, silver is microbiocidal only in the ionic state. 20 Scalzo et al . 21 reported that silver ions reduced microbial concentration by up to 4 log units from the starting inoculum in 6 h and might be suitable for use as a preserving agent. In our experiments, with the mixtures of silver compounds with medium, the bottoms of microcentrifuge tubes and dishes turned dark. This phenomenon is thought to have been caused by the precipitation of insoluble silver compounds. Immature biofilms also darkened in colour, with the biofilms apparently becoming surrounded by a precipitate of silver compounds. After incubation for 24 h at 37°C, the growth rate of S. aureus cells isolated from an impetigo lesion and a furuncle lesion in TSB with 1% silver sulphadiazine or silver nitrate (containing 0.302% silver) was 50-100 times lower than the growth rate of cells in TSB alone (Table IVa) . Simiarly, the colony counts of immature biofilms in plasma with 1% silver sulphadiazine or silver nitrate (containing 0.302% silver) were more than 3000 times lower than those incubated in plasma alone (control), after incubation for 24 h at 37°C (Table IVb) . These results suggest that silver sulphadiazine and silver nitrate have a bactericidal effect against immature biofilms.
The results of this study indicate that silver is more effective in eliminating S. aureus cells in biofilm than in eliminating floating S. aureus cells. Thus silver may be effective in treating S. aureus colonization or infection in patients with skin infections. We suggest that levofloxacin or 10% povidone-iodine in combination with 70% sucrose and silver sulphadiazine or silver nitrate (at a silver concentration of 0.302%) are effective in eliminating S. aureus cells in biofilm. Further studies on staphylococcal biofilm may prove useful in the dermatological field.
